Study of the Bronchoreversibility and Outcomes in Patients with Chronic Obstructive Pulmonary Disease (COPD)
Journal Title: The Egyptian Journal of Hospital Medicine - Year 2018, Vol 72, Issue 11
Abstract
<strong>Background:</strong> acute bronchial reversibility after inhalation of short acting Beta2 agonists (SABA) has been traditionally used to differentiate asthma from chronic obstructive pulmonary disease. However, it is clear that a positive reversibility test does not exclude the diagnosis of chronic obstructive pulmonary disease. About 24% of patients with COPD met the criteria for reversibility.<strong> Aim of the Work:</strong> assessment of airflow reversibility & outcomes in patients with COPD.<strong> Patients and Methods:</strong> this study was conducted at Chest Department, Al-Hussein Hospital, Al-Azhar University and the Chest Hospital in Addakahliah Governorate in the period between January & December 2017. The study included 30 patients with COPD; diagnosed and classified according to [Global initiative for chronic Obstructive Lung Disease (GOLD), 2017].<strong> Results:</strong> mean PFT (FEV1, FEV1 / Pred. FVC % and PEFR) showed no statistically difference pre and post BDT. There was highly statistically significant difference in PFTs (FEV1, FEV1 / Pred. FVC % and PEFR) at 4, 6 and 8 weeks compared to Pre BDT. A highly statistically significant improvement in ABG (PaO2, PaCO2 and pH) was found through weeks of study compared to baseline ABG. CAT test results showed highly significant improvement after 8 weeks compared to 0 week.<strong> Conclusion:</strong> bronchoreversibility is not determined from the first session of nebulizer. Moreover, mostly there is no difference in pulmonary functions mainly forced expiratory volume in the first second between pre and post bronchodilator inhalation. To judge if there is airflow reversibility or not, we must give the patient complete course of treatment for at least one month. Therefore, the lack of acute response to short acting Beta2 agonists does not preclude the beneficial long-term response maintenance bronchodilator treatment.
Authors and Affiliations
Eman Helal
Keywords
Related Articles
- EP ID EP584389
- DOI 10.12816/ejhm.2018.11550
- Views 107
- Downloads 0
Maximizing Resection of Diffused Low-Grade Glioma Functional Outcome
<span>Background: </span><span>most of adults with Diffuse Low Grade Gliomas (DLGGs) are diagnosed with an average age of 39 years and the diagnosis is often made around fully functioning individuals. Currently extent of...
Hyperbaric Oxygen Therapy in Plastic Surgery
<strong>Objective:</strong> In this review the literature aims to familiarize the reader with several of the more common plastic surgery problems and to review the appropriate use of HBO for each condition. Plastic surge...
Type 1 Diabetes Mellitus among Adolescent Girls in Riyadh City, Saudi Arabia
<strong>Background:</strong> Diabetes mellitus (DM) is rapidly becoming one of the main health issues among humans in the 21<sup>st</sup> century. The increase in the incidence of type 1 diabetes has been observed as a...
Rheumatoid Arthritis, Pathophysiology and Management
<strong>Introduction:</strong> Rheumatoid arthritis is considered one of the most common, and particularly attacks the joint causing significant individual and community burden, and present with articular as well as extr...
Associated Factors of Post Renal Transplant Failure
Renal transplantation is the best management for patients suffering from end-stage renal disease (ESRD). It has many benefits which overcome the complications of dialysis, it has some acute and long term complications t...